Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells
暂无分享,去创建一个
N. Taylor | A. Sergé | Quanzhen Li | D. Klatzmann | Alice Machado | D. Cesana | F. Benedicenti | E. Montini | M. Irla | A. Calabria | V. Zimmermann | O. Adjali | Indu Raman | M. Guilbaud | M. Pouzolles | Pierre Barennes | S. Gailhac | Arnauld Sergé | Magali Irla
[1] J. Puck,et al. Lentiviral Gene Therapy Combined with Low‐Dose Busulfan in Infants with SCID‐X1 , 2019, The New England journal of medicine.
[2] Neel H. Shah,et al. ZAP-70 in Signaling, Biology, and Disease. , 2018, Annual review of immunology.
[3] B. Wilhelm,et al. Humoral Immune Response After Intravitreal But Not After Subretinal AAV8 in Primates and Patients. , 2018, Investigative ophthalmology & visual science.
[4] L. Notarangelo,et al. Efficacy of lentivirus‐mediated gene therapy in an Omenn syndrome recombination‐activating gene 2 mouse model is not hindered by inflammation and immune dysregulation , 2017, The Journal of allergy and clinical immunology.
[5] B. Wilhelm,et al. AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] G. Ronzitti,et al. Emerging Issues in AAV-Mediated In Vivo Gene Therapy , 2017, Molecular therapy. Methods & clinical development.
[7] F. Mingozzi,et al. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial , 2017, Human gene therapy.
[8] A. Singer,et al. Identification of lineage-specifying cytokines that signal all CD8-cytotoxic lineage fate decisions in the thymus , 2017, Nature Immunology.
[9] R. Jenq,et al. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease. , 2017, Blood.
[10] Thomas Voit,et al. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy , 2017, Nature Communications.
[11] Nolan J Brown,et al. Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes? , 2017, Human gene therapy.
[12] R. Grange,et al. Long‐term effects of systemic gene therapy in a canine model of myotubular myopathy , 2017, Muscle & nerve.
[13] Jason S. Mitchell,et al. T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. , 2017, JCI insight.
[14] M. V. D. van den Brink,et al. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency , 2017, Journal of Hematology & Oncology.
[15] Yasmine El-Shamayleh,et al. AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses. , 2017, Journal of neurophysiology.
[16] Barbara Engel,et al. Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency , 2017, The Journal of clinical investigation.
[17] M. Irla,et al. Administration of RANKL boosts thymic regeneration upon bone marrow transplantation , 2017, EMBO molecular medicine.
[18] L. Naldini,et al. Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products , 2017, EMBO molecular medicine.
[19] R. Grange,et al. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] R. Chandler,et al. Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models. , 2017, Human gene therapy.
[21] James M. Wilson,et al. Regulatory and Exhausted T Cell Responses to AAV Capsid. , 2017, Human gene therapy.
[22] L. Notarangelo,et al. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects afte , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] T. Flotte,et al. Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency , 2017, Proceedings of the National Academy of Sciences.
[24] S. Weger,et al. High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence , 2016, Journal of Virology.
[25] A. Srivastava,et al. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing , 2016, Scientific Reports.
[26] A. Singer,et al. Timing and duration of MHC I positive selection signals are adjusted in the thymus to prevent lineage errors , 2016, Nature Immunology.
[27] Z. Jing,et al. αβ T-cell receptor bias in disease and therapy (Review). , 2016, International journal of oncology.
[28] R. Herzog,et al. Clinical development of gene therapy: results and lessons from recent successes , 2016, Molecular therapy. Methods & clinical development.
[29] L. Notarangelo,et al. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency , 2016, Science Translational Medicine.
[30] J. Abramson,et al. AIRE: From promiscuous molecular partnerships to promiscuous gene expression , 2016, European journal of immunology.
[31] J. B. Oliveira,et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. , 2015, The Journal of clinical investigation.
[32] E. Meffre,et al. Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients. , 2015, The Journal of clinical investigation.
[33] H. Büning,et al. Engineering the AAV capsid to optimize vector-host-interactions. , 2015, Current opinion in pharmacology.
[34] M. van der Burg,et al. B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome , 2015, The Journal of allergy and clinical immunology.
[35] Arnauld Sergé,et al. For3D: Full organ reconstruction in 3D, an automatized tool for deciphering the complexity of lymphoid organs. , 2015, Journal of immunological methods.
[36] A. Sergé,et al. Thymic Crosstalk Coordinates Medulla Organization and T-Cell Tolerance Induction , 2015, Front. Immunol..
[37] Mikhail Shugay,et al. MiXCR: software for comprehensive adaptive immunity profiling , 2015, Nature Methods.
[38] Frederic D Bushman,et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. , 2015, JAMA.
[39] Haochu Huang,et al. The development and function of thymic B cells , 2015, Cellular and Molecular Life Sciences.
[40] M. Agbandje-McKenna,et al. Gene transfer properties and structural modeling of human stem cell-derived AAV. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[41] T. Conlon,et al. B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study , 2014, Molecular therapy. Methods & clinical development.
[42] A. Bhandoola,et al. Chemokine treatment rescues profound T-lineage progenitor homing defect after bone marrow transplant conditioning in mice. , 2014, Blood.
[43] Yosvany López,et al. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites , 2014, Genome Medicine.
[44] T. Radstake,et al. The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells. , 2014, Stem cells and development.
[45] D. Shah,et al. An Overview of the Intrathymic Intricacies of T Cell Development , 2014, The Journal of Immunology.
[46] Emily R. Levy,et al. Image-guided intrathymic injection of multipotent stem cells supports lifelong T-cell immunity and facilitates targeted immunotherapy. , 2014, Blood.
[47] M. V. D. van den Brink,et al. Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. , 2013, Blood.
[48] T. Flotte,et al. Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression. , 2013, The Journal of clinical investigation.
[49] Emily R. Levy,et al. Sex steroid blockade enhances thymopoiesis by modulating Notch signaling , 2013, The Journal of experimental medicine.
[50] L. Meng,et al. Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection , 2013, Proceedings of the National Academy of Sciences.
[51] Luca Biasco,et al. Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome , 2013, Science.
[52] A. Thrasher,et al. Gene therapy for PIDs: Progress, pitfalls and prospects , 2013, Gene.
[53] A. Fischer,et al. Gene therapy of primary T cell immunodeficiencies. , 2013, Gene.
[54] Liujiang Song,et al. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. , 2013, Cytotherapy.
[55] K. High,et al. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. , 2013, Blood.
[56] N. Taylor,et al. Concise Review: Hematopoietic Stem Cell Transplantation: Targeting the Thymus , 2013, Stem cells.
[57] J. Caamaño,et al. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development , 2013, The Journal of experimental medicine.
[58] N. Taylor,et al. Intrathymic progenitor cell transplantation across histocompatibility barriers results in the persistence of early thymic progenitors and T-cell differentiation. , 2013, Blood.
[59] A. Sergé,et al. Antigen Recognition By Autoreactive Cd4+ Thymocytes Drives Homeostasis Of The Thymic Medulla , 2012, PloS one.
[60] M. Cavazzana‐Calvo,et al. Human T-Lymphoid Progenitors Generated in a Feeder-Cell-Free Delta-Like-4 Culture System Promote T-Cell Reconstitution in NOD/SCID/γc−/− Mice , 2012, Stem cells.
[61] Christof von Kalle,et al. Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] R. Jenq,et al. Interleukin-22 Drives Endogenous Thymic Regeneration in Mice , 2012, Science.
[63] A. Fischer,et al. Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency , 2011, Front. Immun..
[64] M. V. D. van den Brink,et al. Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation. , 2011, Best practice & research. Clinical haematology.
[65] A. Bhandoola,et al. Signal integration and crosstalk during thymocyte migration and emigration , 2011, Nature reviews. Immunology.
[66] A. Davidoff,et al. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine , 2011, Gene Therapy.
[67] F. Alt,et al. Abnormalities of Thymic Stroma may Contribute to Immune Dysregulation in Murine Models of Leaky Severe Combined Immunodeficiency , 2011, Front. Immun..
[68] E. Palmer,et al. Signaling in thymic selection. , 2011, Current opinion in immunology.
[69] F. Bushman,et al. The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones , 2011, Blood.
[70] M. Hallek,et al. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors. , 2010, Experimental hematology.
[71] T. Heng,et al. Sex Steroid Ablation Enhances Immune Reconstitution Following Cytotoxic Antineoplastic Therapy in Young Mice , 2010, The Journal of Immunology.
[72] A. Fischer,et al. Gene therapy for primary immunodeficiencies. , 2010, Immunology and allergy clinics of North America.
[73] L. Muul,et al. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants. , 2010, Clinical immunology.
[74] N. Taylor,et al. Intrathymic transplantation of bone marrow-derived progenitors provides long-term thymopoiesis. , 2010, Blood.
[75] Hans Martin,et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease , 2010, Nature Medicine.
[76] Alessandro Aiuti,et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. , 2009, The New England journal of medicine.
[77] N. Taylor,et al. Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[78] U. Pannicke,et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. , 2008, Blood.
[79] A. Singer,et al. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice , 2008, Nature Reviews Immunology.
[80] Christine Kinnon,et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.
[81] F. Bushman,et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.
[82] Michael J. DiCola,et al. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome. , 2008, Blood.
[83] C. Nguyen,et al. ZAP-70 Restoration in Mice by In Vivo Thymic Electroporation , 2008, PloS one.
[84] L. Zhong,et al. Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model. , 2008, Human gene therapy.
[85] L. Zhong,et al. Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells. , 2008, Human gene therapy.
[86] David Klatzmann,et al. Comprehensive Assessment and Mathematical Modeling of T Cell Population Dynamics and Homeostasis1 , 2008, The Journal of Immunology.
[87] B. Kyewski,et al. Promiscuous gene expression and the developmental dynamics of medullary thymic epithelial cells , 2007, European journal of immunology.
[88] K. Hogquist,et al. Thymic emigration revisited , 2007, The Journal of experimental medicine.
[89] C. Benoist,et al. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire , 2007, The Journal of experimental medicine.
[90] D. Russell. AAV vectors, insertional mutagenesis, and cancer. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[91] A. Gudkov,et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. , 2007, Blood.
[92] D. Min,et al. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. , 2007, Blood.
[93] N. Olsen,et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes , 2006, Clinical and experimental immunology.
[94] D. Klatzmann,et al. Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors. , 2006, Blood.
[95] T. Wada,et al. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. , 2006, Blood.
[96] A. Schambach,et al. Gene therapy: X-SCID transgene leukaemogenicity , 2006, Nature.
[97] F. Rieux-Laucat,et al. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. , 2006, The New England journal of medicine.
[98] A. Douar,et al. Gene Therapy Progress and Prospects – Vectorology: design and production of expression cassettes in AAV vectors , 2006, Gene Therapy.
[99] J. Cooper,et al. CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[100] N. Hackett,et al. AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL , 2005, Gene Therapy.
[101] N. Taylor,et al. Intrathymic administration of hematopoietic progenitor cells enhances T cell reconstitution in ZAP-70 severe combined immunodeficiency. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[102] Y. Hayashi,et al. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. , 2005, Blood.
[103] T. Heng,et al. Activation of Thymic Regeneration in Mice and Humans following Androgen Blockade , 2005, The Journal of Immunology.
[104] N. Taylor,et al. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer. , 2005, The Journal of clinical investigation.
[105] J. Sprent,et al. Regulation of mature T cell homeostasis. , 2005, Seminars in immunology.
[106] H. Petrie,et al. Regulation of Thymus Size by Competition for Stromal Niches among Early T Cell Progenitors1 , 2004, The Journal of Immunology.
[107] T. Nakahata,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2004 .
[108] H. Bujard,et al. Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[109] N. Manley,et al. A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation , 2003, Nature Immunology.
[110] M. Kay,et al. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[111] F. Candotti,et al. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. , 2003, The Journal of clinical investigation.
[112] B. Aronow,et al. Restricting Zap70 Expression to CD4+CD8+ Thymocytes Reveals a T Cell Receptor–dependent Proofreading Mechanism Controlling the Completion of Positive Selection , 2003, The Journal of experimental medicine.
[113] Mark S. Anderson,et al. Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.
[114] K. Yamaguchi,et al. T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. , 2001, Blood.
[115] I. Goldschneider,et al. The Importation of Hematogenous Precursors by the Thymus Is a Gated Phenomenon in Normal Adult Mice , 2001, The Journal of experimental medicine.
[116] J. Wilson,et al. Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[117] V. Wahn,et al. Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[118] S. Berzins,et al. The Role of the Thymus and Recent Thymic Migrants in the Maintenance of the Adult Peripheral Lymphocyte Pool , 1998, The Journal of experimental medicine.
[119] A. Salvetti,et al. Factors influencing recombinant adeno-associated virus production. , 1998, Human gene therapy.
[120] R. DeMatteo,et al. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression , 1997, Journal of virology.
[121] A. Nienhuis,et al. High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3' gamma globin gene regulatory element and integrates as tandem copies in erythroid cells. , 1997, Blood.
[122] P. Malik,et al. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line , 1997, Journal of virology.
[123] Juan Li,et al. Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System , 1997, Experimental Neurology.
[124] R. Strumpf,et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. , 1996, The Annals of thoracic surgery.
[125] U. Dirksen,et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. , 1996, The New England journal of medicine.
[126] J. Puck,et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency , 1996, Nature Genetics.
[127] G. Breese,et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector , 1996, Brain Research.
[128] J. Sprent,et al. Thymus-grafted SCID mice show transient thymopoiesis and limited depletion of V beta 11+ T cells , 1992, The Journal of experimental medicine.
[129] G. Spangrude,et al. Differentiation of hematopoietic stem cells in irradiated mouse thymic lobes. Kinetics and phenotype of progeny. , 1990, Journal of immunology.
[130] M. Claesson,et al. Thymic Epithelial Cells , 1990, Scandinavian journal of immunology.
[131] Mark M. Davis,et al. T-cell antigen receptor genes and T-cell recognition , 1988, Nature.
[132] R. Scollay,et al. Dynamics of Early T Cells: Prothymocyte Migration and Proliferation in the Adult Mouse Thymus , 1986, Immunological reviews.
[133] D. Greiner,et al. Studies of thymocytopoiesis in rats and mice. I. Kinetics of appearance of thymocytes using a direct intrathymic adoptive transfer assay for thymocyte precursors , 1986, The Journal of experimental medicine.
[134] A. Bhandoola,et al. Intrathymic Injection. , 2016, Methods in molecular biology.
[135] H. Waldmann,et al. Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade. , 2015, Human gene therapy.
[136] I. Anegon,et al. Measuring immune responses to recombinant AAV gene transfer. , 2011, Methods in molecular biology.
[137] L. Sellner,et al. Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells. , 2010, Cytotherapy.
[138] S. Holland,et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). , 2008, Blood.
[139] E. Spanopoulou,et al. Thymic microenvironments, 3-D versus 2-D? , 1999, Seminars in immunology.
[140] Donald W. Pfaff,et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain , 1994, Nature Genetics.
[141] Susan M. Schlenner,et al. Thymus-autonomous T cell development in the absence of progenitor import , 2012, The Journal of experimental medicine.
[142] J. D. Di Santo,et al. Brief Definitive Report , 2022 .